ceftibuten isolate e coli k pneumoniae p aeruginosa atcc 25922 nctc 13353 atcc baa 2523 atcc baa 1705 atcc 700603 cdc 0504 atcc  (ATCC)

Journal: BMC Microbiology

Article Title: Combatting biofilm formation of Klebsiella pneumoniae and Bacillus subtilis clinical strains from the oral cavity using biogenic Se-NPs: molecular docking simulation and cytotoxic effects on HepG2 cancer cells

doi: 10.1186/s12866-025-04142-w

Figure Lengend Snippet: Antibacterial and MIC of Se-NPs against the most virulent clinical strains. A : Hexitol as appositive control and different concentrations of Se-NPs against K. pneumoniae A11, B : Hexitol as a positive control and different concentrations of Se-NPs against B. subtilis A33 strain

Article Snippet: The National Center for Biotechnology Information (NCBI) received clinical isolates of K. pneumoniae A11 and B. subtilis A33, which were assigned accession numbers PP995146 and PP995148 , respectively.

Techniques: Control, Positive Control

Journal: BMC Microbiology

Article Title: Combatting biofilm formation of Klebsiella pneumoniae and Bacillus subtilis clinical strains from the oral cavity using biogenic Se-NPs: molecular docking simulation and cytotoxic effects on HepG2 cancer cells

doi: 10.1186/s12866-025-04142-w

Figure Lengend Snippet: Effect of Se-NPs on Biofilm activity of K. pneumoniae A11strain

Article Snippet: The National Center for Biotechnology Information (NCBI) received clinical isolates of K. pneumoniae A11 and B. subtilis A33, which were assigned accession numbers PP995146 and PP995148 , respectively.

Techniques: Activity Assay

Journal: BMC Microbiology

Article Title: Combatting biofilm formation of Klebsiella pneumoniae and Bacillus subtilis clinical strains from the oral cavity using biogenic Se-NPs: molecular docking simulation and cytotoxic effects on HepG2 cancer cells

doi: 10.1186/s12866-025-04142-w

Figure Lengend Snippet: a 3D crystallography of LuxS Synthase in K. pneumoniae (PDB: 1INN), b 3D crystallography of the biofilm matrix promoter AbbA from B. subtilis obtained from protein data bank

Article Snippet: The National Center for Biotechnology Information (NCBI) received clinical isolates of K. pneumoniae A11 and B. subtilis A33, which were assigned accession numbers PP995146 and PP995148 , respectively.

Techniques:

Journal: BMC Microbiology

Article Title: Combatting biofilm formation of Klebsiella pneumoniae and Bacillus subtilis clinical strains from the oral cavity using biogenic Se-NPs: molecular docking simulation and cytotoxic effects on HepG2 cancer cells

doi: 10.1186/s12866-025-04142-w

Figure Lengend Snippet: Structure of the Eugenol within the active site of LuxS synthase in K. pneumoniae (PDB: 1INN) ( a ) 3D Structure shown the binding mode of Se-NPs inside the pocket with amino acid interaction ( b ) 2D Structure shown the binding mode of Se-NPs inside the pocket with amino acid interaction

Article Snippet: The National Center for Biotechnology Information (NCBI) received clinical isolates of K. pneumoniae A11 and B. subtilis A33, which were assigned accession numbers PP995146 and PP995148 , respectively.

Techniques: Binding Assay

Journal: Eurosurveillance

Article Title: Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in Klebsiella pneumoniae : a European Antimicrobial Resistance Genes Surveillance Network investigation, Europe, February 2019 to October 2024

doi: 10.2807/1560-7917.ES.2025.30.27.2500439

Figure Lengend Snippet: Phylogenetic tree of Klebsiella pneumoniae isolates carrying the mosaic resistance and virulence plasmid, February 2019–October 2024 (n = 604)

Article Snippet: In addition, we completed the dataset with sequences of K. pneumoniae isolates exhibiting the key markers from previous ECDC investigations (n = 76) and from the National Center for Biotechnology Information (NCBI) Pathogen Detection and NCBI RefSeq databases (n = 1,139), as further detailed in the Supplement , excluding duplicates.

Techniques: Plasmid Preparation

Journal: Eurosurveillance

Article Title: Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in Klebsiella pneumoniae : a European Antimicrobial Resistance Genes Surveillance Network investigation, Europe, February 2019 to October 2024

doi: 10.2807/1560-7917.ES.2025.30.27.2500439

Figure Lengend Snippet: Time distribution a of Klebsiella pneumoniae isolates carrying the mosaic resistance and virulence plasmid by country, February 2019–October 2024 (n = 604)

Article Snippet: In addition, we completed the dataset with sequences of K. pneumoniae isolates exhibiting the key markers from previous ECDC investigations (n = 76) and from the National Center for Biotechnology Information (NCBI) Pathogen Detection and NCBI RefSeq databases (n = 1,139), as further detailed in the Supplement , excluding duplicates.

Techniques: Plasmid Preparation